9 , 10 The negative influence of progression of the disease is highly significant in patients, which necessitates the development of both pharmacological and nonpharmacological evidence-based management strategies.
← all excerpts
Management of COPD, equal treatment across age, gender, and social situation? A register study.
1
—
—